Mutation in the Disordered Linker Region of Capsid Disrupts Viral Kinetics of a Neuropathogenic SIV in Rhesus

Cheri A Lee1, Vanessa M Hirsch1

  • 1Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Microbiology Spectrum
|March 17, 2022
PubMed

Insights

Researchers developed a simian immunodeficiency virus (SIV) clone that causes neuroAIDS in rhesus macaques irrespective of their TRIM5α genotype. This breakthrough overcomes limitations in SIV studies and enhances understanding of viral infectivity.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Simian immunodeficiency virus (SIV) infection in rhesus macaques (RM) is a key model for AIDS research.
  • TRIM5α gene polymorphisms in RM restrict SIV replication, necessitating genetic screening and limiting available animal models.
  • Previous work identified TRIM5α B30.2/SPRY domain polymorphisms affecting SIVsmm viremia and capsid N-terminal domain (CA-NTD) substitutions enabling SIV to overcome TRIM5α restriction.

Purpose of the Study:

  • To create a TRIM5α-resistant SIV clone that overcomes TRIM5α restriction in RM.
  • To investigate viral replication and neuroAIDS development in RM with different TRIM5α genotypes.
  • To identify viral factors influencing infectivity and host restriction.

Main Methods:

  • Generation of a TRIM5α-resistant SIV clone (CL757-SS) with specific capsid N-terminal domain (CA-NTD) substitutions.
  • Infection of rhesus macaques with different TRIM5α genotypes (TFP/Q and TFP/TFP) using the parental and engineered SIV clones.
  • Analysis of viral replication, emergence of mutations, and central nervous system (CNS) lesion development.

Main Results:

  • The engineered CL757-SS clone showed impaired replication in both permissive (TFP/Q) and restrictive (TFP/TFP) TRIM5α genotypes.
  • A pre-existing P146T substitution in the capsid C-terminal domain (CA-CTD) disordered linker region was discovered in emerging viruses.
  • Restoring the P146 residue to proline in the context of TRIM5α-SS escape mutations restored viral replication and enhanced neurotropic clone infectivity across TRIM5α genotypes.

Conclusions:

  • A novel SIV clone induces neuroAIDS in rhesus macaques irrespective of TRIM5α genotype, expanding the utility of this animal model.
  • The study highlights the critical role of the CA-CTD disordered linker region in viral infectivity and host restriction.
  • This work provides a valuable tool for AIDS vaccine and antiretroviral therapy development by overcoming TRIM5α-mediated restriction.